FGFR1 and NTRK3 actionable alterations in “Wild-Type” gastrointestinal stromal tumors-Reference-Cited by-同舟云学术

FGFR1 and NTRK3 actionable alterations in “Wild-Type” gastrointestinal stromal tumors

Published:2016-12 Issue:1 Volume:14 Page:
ISSN:1479-5876
Container-title:Journal of Translational Medicine
language:en
Short-container-title:J Transl Med

Author:

Shi Eileen,Chmielecki Juliann,Tang Chih-Min,Wang Kai,Heinrich Michael C.,Kang Guhyun,Corless Christopher L.,Hong David,Fero Katherine E.,Murphy James D.,Fanta Paul T.,Ali Siraj M.,De Siena Martina,Burgoyne Adam M.,Movva Sujana,Madlensky Lisa,Heestand Gregory M.,Trent Jonathan C.,Kurzrock Razelle,Morosini Deborah,Ross Jeffrey S.,Harismendy Olivier,Sicklick Jason K.

Funder

National Institutes of Health

U.S. Department of Veterans Affairs

Publisher

Springer Science and Business Media LLC

Subject

General Biochemistry, Genetics and Molecular Biology,General Medicine

Link

http://link.springer.com/content/pdf/10.1186/s12967-016-1075-6.pdf

Reference49 articles.

1. Ma GL, Murphy JD, Martinez ME, Sicklick JK. Epidemiology of gastrointestinal stromal tumors in the era of histology codes: results of a population-based study. Cancer Epidemiol Biomarkers Prev. 2015;24(1):298–302.

2. Corless CL, Barnett CM, Heinrich MC. Gastrointestinal stromal tumours: origin and molecular oncology. Nat Rev Cancer. 2011;11(12):865–78.